SAN DIEGO, Sept. 18, 2007 (PRIME NEWSWIRE) -- OLAS Pharmaceuticals, a privately-held biotechnology company with patented technologies focused on the use of positive modulators of the AMPA receptor, announced today positive results from its in vivo studies of growth hormone, DHEA, and corticosterone.
